# A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

> **NCT00000947** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 850 (—)

## Conditions studied

- Mycobacterium Avium-intracellulare Infection
- HIV Infections

## Interventions

- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT00000947
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2000-07
- **Target enrollment:** 850 (—)
- **Last updated:** 2021-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000947, "A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00000947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*